HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Siamak Salami Selected Research

Therapeutics

6/2019Screening of acetaminophen-induced alterations in epithelial-to-mesenchymal transition-related expression of microRNAs in a model of stem-like triple-negative breast cancer cells: The possible functional impacts.
4/2019The roles and role-players in thyroid cancer angiogenesis.
9/2018Lipophilic statins antagonistically alter the major epithelial-to-mesenchymal transition signaling pathways in breast cancer stem-like cells via inhibition of the mevalonate pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Siamak Salami Research Topics

Disease

12Breast Neoplasms (Breast Cancer)
01/2021 - 06/2003
12Neoplasms (Cancer)
11/2020 - 10/2005
4Triple Negative Breast Neoplasms
12/2019 - 01/2012
3Prostatic Neoplasms (Prostate Cancer)
04/2015 - 10/2011
2Ovarian Neoplasms (Ovarian Cancer)
01/2021 - 01/2020
2Atherosclerosis
12/2013 - 09/2012
2Ductal Carcinoma
01/2012 - 01/2011
1Ketosis
01/2021
1Starvation
06/2020
1Wounds and Injuries (Trauma)
01/2020
1Thyroid Neoplasms (Thyroid Cancer)
04/2019
1Neoplasm Metastasis (Metastasis)
09/2018
1Carcinoma (Carcinomatosis)
01/2017
1Head and Neck Neoplasms (Head and Neck Cancer)
01/2017
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2013
1Breast Diseases (Breast Disease)
01/2010
1Diabetic Cardiomyopathies
09/2009
1Atrophy
07/2009
1Hyperhomocysteinemia
07/2009
1Alcoholism (Alcohol Abuse)
07/2009
1Alcohol-Induced Disorders
01/2008

Drug/Important Bio-Agent (IBA)

4Glucose (Dextrose)FDA LinkGeneric
01/2021 - 04/2015
3ParaffinIBA
06/2020 - 01/2011
3shikoninIBA
01/2018 - 01/2015
2Pharmaceutical PreparationsIBA
01/2021 - 04/2016
2Caspase 3 (Caspase-3)IBA
01/2021 - 01/2017
23-Hydroxybutyric Acid (beta-Hydroxybutyric Acid)IBA
01/2021 - 12/2019
2Histones (Histone)IBA
06/2020 - 12/2019
2Estrogen ReceptorsIBA
01/2018 - 06/2003
2HomocysteineIBA
12/2013 - 07/2009
2Ethanol (Ethyl Alcohol)IBA
09/2012 - 07/2009
2Cyclic GMP-Dependent Protein Kinases (Protein Kinase G)IBA
04/2012 - 09/2011
2GuanosineIBA
04/2012 - 09/2011
2Purinergic P1 Receptors (Adenosine Receptor)IBA
03/2012 - 10/2011
2AndrogensIBA
03/2012 - 10/2011
2Formaldehyde (Formol)FDA Link
01/2012 - 01/2011
2IsoenzymesIBA
01/2010 - 10/2005
2Adenosine DeaminaseIBA
01/2010 - 10/2005
2Vitamin EFDA LinkGeneric
09/2009 - 07/2009
1Annexin A5IBA
01/2021
1biliverdin reductaseIBA
01/2021
1Adenosine Triphosphate (ATP)IBA
01/2021
1Biliverdine (Biliverdin)IBA
01/2021
1Dithionitrobenzoic Acid (Ellman's Reagent)IBA
01/2021
1Quinacrine (Mepacrine)IBA
11/2020
1Aminacrine (Aminoacridine)IBA
11/2020
1Lysine (L-Lysine)FDA Link
06/2020
1AgarIBA
01/2020
1KetonesIBA
12/2019
1MicroRNAs (MicroRNA)IBA
06/2019
1Acetaminophen (Paracetamol)FDA LinkGeneric
06/2019
1Vascular Endothelial Growth FactorsIBA
04/2019
1Biomarkers (Surrogate Marker)IBA
04/2019
1Atorvastatin (Lipitor)FDA Link
09/2018
1Simvastatin (Zocor)FDA LinkGeneric
09/2018
1Lovastatin (Mevacor)FDA LinkGeneric
09/2018
1Mevalonic Acid (Mevalonate)IBA
09/2018
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
09/2018
1Protein Kinases (Protein Kinase)IBA
01/2018
1NaphthoquinonesIBA
01/2018
1coumarinIBA
01/2017
1CoumarinsIBA
01/2017
1BenzoxazolesIBA
01/2017
1Death Domain ReceptorsIBA
01/2017
1Fatty Acids (Saturated Fatty Acids)IBA
04/2015
1EnzymesIBA
04/2015
1HexokinaseIBA
04/2015
1Reactive Oxygen Species (Oxygen Radicals)IBA
01/2015
1oxidized low density lipoproteinIBA
12/2013
1CytokinesIBA
01/2013
1Interleukin-1 (Interleukin 1)IBA
01/2013
1Interleukin-18 (Interleukin 18)IBA
01/2013
1Protein Isoforms (Isoforms)IBA
04/2012
1Adenosine (Adenocard)FDA LinkGeneric
03/2012
1Estrogen Receptor alphaIBA
01/2012
1N(6)- (3- iodobenzyl)- 5'- N- methylcarboxamidoadenosineIBA
10/2011
1Cyclic GMPIBA
09/2011
1Progesterone Receptors (Progesterone Receptor)IBA
01/2011
1Estrogens (Estrogen)FDA Link
01/2011
1Proteins (Proteins, Gene)FDA Link
09/2009
1Thioctic Acid (Lipoic Acid)IBA
01/2008
1AntioxidantsIBA
01/2008
1TamoxifenFDA LinkGeneric
06/2003

Therapy/Procedure

3Therapeutics
06/2019 - 09/2018
2Ketogenic Diet
01/2021 - 01/2020